Mayo Clinic clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
45 trials changed in the last 30 days: 2 stopped, 24 with notable changes, 19 with minor changes only.
- Notable: Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation Phase changed: Phase 2/3 → Phase 3
- Notable: Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy · Newly Diagnosed Glioblastoma, SAGA 2.0 Trial Recruitment opened
- Minor: Usability of a Chest-Strap Ambulatory ECG Monitor in Active Individuals in Comparison With a Traditional Ambulatory ECG Patch Monitor (MoMe ARC) Primary completion pushed from Feb 23, 2027 to Apr 23, 2027
- Notable: Mechanisms of Resistance Exercise Training for Improved Muscle Insulin Sensitivity Primary completion pushed from Aug 31, 2028 to Sep 1, 2029
- Minor: Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients Enrollment closed, study ongoing
- Minor: Personalized Education and Genetic Counseling to Increase Genetic Testing · a Known Family History of Pancreatic Cancer Trial status changed: Enrolling by Invitation → Completed
- Minor: Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study Trial sites expanded: 36 → 39 locations
- Notable: Reduced Dose Radiotherapy · Indolent Non-Hodgkin Lymphoma Primary completion pushed from May 30, 2027 to May 30, 2029
- Stopped: Immune Response to Anti-HER2 Therapies · HER2-Positive Stage I-IV Breast Cancer Trial terminated
- Notable: At-Home Cancer Directed Therapy Versus in Clinic · Advanced Cancer Primary completion pushed from Jan 1, 2027 to Dec 1, 2027
- Notable: Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia Primary completion pushed from Dec 31, 2026 to Dec 31, 2028
- Notable: Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery · Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial Recruitment opened
- Minor: Home Cancer Therapy Versus In Clinic Cancer Therapy in Black · Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer Primary and study completion pushed from Aug 27, 2028 to Sep 29, 2028
- Notable: ECHO · Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer Primary completion pushed from Dec 31, 2026 to Jul 30, 2027
- Notable: Conducting Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up for Post-discharge Ostomy Patients to Reduce Hospital Readmission Primary endpoint(s) modified
- Notable: Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 · Diffuse or High Grade Glioma Primary and study completion dates pushed to Feb 29, 2028
- Notable: Virtual Reality for Non-cardiac Chest Pain Primary and study completion dates pushed to Dec 31, 2027
- Notable: CLEOPATRA · EEG-Guided Transcranial Magnetic Stimulation · Depression Recruitment opened
- Minor: COVID-FISETIN · SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation Primary and study completion pushed from Sep 2026 to Mar 2027
- Minor: Metabolic Impact of Pancreatic Duct Decompression Start date changed from estimate of Sep 30, 2026 to Oct 30, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-18 | NCT07944222 PIONEER: POLR2 Investigation Of Natural History, OutcomEs, and Evaluation for Research | Not Yet Recruiting | |
| 2026-11-13 | NCT07935889 Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the… | Phase 3 | Recruiting |
| 2026-11-12 | NCT07931105 Effectiveness of Two Diaphragmatic Strengthening Programs on Symptoms of LPR as Measured… | Completed | |
| 2026-11-09 | NCT07923877 Induction Chemoimmunotherapy to Prevent Laryngectomy in Advanced Laryngeal Cancer and… | Phase 2 | Not Yet Recruiting |
| 2026-11-09 | NCT07924735 Opioid Sparing Cognitive Behavioral Therapy (CBT) Intervention to Manage Acute Pain, and… | Active, Not Recruiting | |
| 2026-10-30 | NCT07905911 Maximum Lysis on Thromboelastography as a Marker of Systemic Severity in Acute Allergic… | Recruiting | |
| 2026-10-29 | NCT07904377 ACORYS AI4AF PILOT STUDY | Recruiting | |
| 2026-10-28 | NCT07900646 Peri-procedural Weighted Blanket Use for ECT | Not Yet Recruiting | |
| 2026-10-26 | NCT07893457 Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric… | Phase 4 | Not Yet Recruiting |
| 2026-10-22 | NCT07890402 A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the… | Recruiting |
Active trials by phase
| Early Phase 1 | 19 | |
| Phase 1 | 37 | |
| Phase 1/2 | 17 | |
| Phase 2 | 108 | |
| Phase 2/3 | 2 | |
| Phase 3 | 14 | |
| Phase 4 | 50 |
Not charted: 576 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 68
Heart Disease (52) · Breast Cancer (48) · Obesity (29) · Prostate Cancer (27) · Glioma (24) · Diabetes (20) · Head & Neck Cancer (20) · Dementia (19) · Leukemia (19) · Lung Cancer (19)
Get alerts when Mayo Clinic's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.